News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-11-08 9:28:50 pm AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2023 Earnings Call Transcript SeekingAlpha
2023-11-08 2:22:46 pm AcelRx Pharmaceuticals: Q3 Earnings Snapshot Associated Press Finance
2023-11-08 1:5:0 pm AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire
2023-11-07 1:5:0 pm AcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study PR Newswire
2023-10-26 1:30:0 pm AcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023 PR Newswire
2023-10-03 5:30:0 am AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study PR Newswire
2023-09-12 10:2:49 am Insider Buying: CEO Vincent Angotti Acquires 10,000 Shares of AcelRx Pharmaceuticals Inc GuruFocus.com
2023-09-06 5:30:0 am AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference PR Newswire
2023-08-22 2:30:34 pm What Makes AcelRx Pharmaceuticals (ACRX) a New Buy Stock Zacks
   

Please consider a small donation if you think this website provides you with relevant information